SUMMARY Ten patients with spasmodic torticollis were treated by injection of a total dose of 30 ng of botulinum toxin type A into the affected sternomastoid and posterior cervical muscles. Nine patients reported improvement in head position and control, which was confirmed in seven cases by clinical assessment and "blind" videotape ratings before and 6 weeks after injection. Five patients who had pain reported relief. Seven patients had mild transient dysphagia after injection; two who were given a more concentrated solution of the toxin developed more severe dysphagia, but this also recovered. Other minor transient side effects included weakness of the voice and local pain. The beneficial effects of botulinum toxin injections lasted some 2 to 3 months. A slight reduction in the total dose of toxin injected avoided the main side effects, and this method of treatment appears to offer successful control of head position and pain in the majority of patients with torticollis.
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Spasmodic torticollis is difficult to treat. Little is known about its underlying pathogenesis, so therapy has been symptomatic.
Biofeedback and behavioural modification have been used' 2 but unfortunately without convincing long term success. Numerous drugs have been reported to produce benefit in some patients with torticollis, 3 (1) Severity of torticollis (0-4) at "rest" for both (a) deviation and (b) jerks.
(2) Severity of torticollis (04) (14) , see Methods. 2The scores of each of the two "blind" raters is shown. For statistical analysis, the mean of the two scores was used.
3Self-rating by patients of benefit on scale of 0 (no benefit) to 3 (marked) 6 Improvement appeared from 4 days to 2 weeks (mean 6-6 days) after injection, and reached its peak from 10 days to 3 weeks (mean 10-1 days). The duration of improvement measured from its onset until the first evidence of deterioration ranged from 8 to 15 weeks (mean 
weeks).
In total, five patients had neck or shoulder pain prior to treatment. This pain was completely relieved in four cases, and in the other it was greatly improved so that oral analgesics were no longer required. Relief of pain began 4-7 days after injection. Pain recurred in all five patients when head position and control deteriorated.
Side effects were experienced to some degree by all patients (table 2). The most common was dysphagia which occurred in nine patients. This was mild in Stell, Thompson, Marsden seven, producing minimal disability, and noted mainly with dry solids. In patients 8 and 9 dysphagia was severe with difficulty swallowing saliva, liquids and solids. Attempts to swallow anything but sips of water produced aspiration and coughing. Patient 9 had a previous history of intermittent choking on solids though not liquids for some years, but had not been investigated for this previously. Both patients were admitted for observation 2 to 3 weeks after injection. Neither required rehydration. Nutrition was provided by using the semi-solid food supplement "Complan" which was well tolerated. In patient 8, a barium swallow was normal, but laryngoscopy revealed pooling of saliva in the pyriform fossa and reduced motility of the right vocal cord. In patient 9, there was pooling of barium in the oropharynx with prominent aspiration of barium, but oesophageal contractility was normal. Laryngoscopy revealed considerable saliva pooling and a right vocal cord paralysis. In both patients repeated laryngoscopy 3 weeks later demonstrated complete recovery of vocal cord motility. Both these patients had received botulinum toxin into their left sternomastoid and right splenius capitus muscles in the same manner as in other patients, except that in these two the solution was more concentrated (the same total dose being dissolved in half the volume).
In general, dysphagia began 2-10 days after injection and lasted 4 days to I month; complete resolution occurred in all patients.
Five patients complained of dysphonia. This was mild and consisted of a slight deepening and reduction in volume of the voice. It began 2-7 days after injection, and lasted for a maximum of 6 weeks.
Two patients complained of transient dryness of the throat, two complained of generalised asthenia without weakness, and one patient complained of 10 patients, but was only disabling in a further two cases. Both were treated with a more concentrated solution of toxin, and it may have been that the higher gradient of solute facilitated toxin diffusion into the subjacent pharyngeal plexus and muscles when injecting the sternomastoid. However, it is difficult to explain why both developed a right vocal cord paresis after the left sternomastoid and right splenius capitus injections. It seems unlikely that local spread of toxin from these muscles could involve the right pharyngeal plexus. Retrograde transport of botulinum toxin has been previously reported,17 as has transynaptic spread of toxin with entry into the spinal cord,'8 but the biological significance of this is not known. Despite the disability noted by the two most severely affected patients, neither required parenteral nutrition, and both recovered completely several weeks before the beneficial effects of the toxin waned. Other side effects, including dysphonia, dry throat, lethargy and local pain, were mild and recovered completely within a few weeks.
The frequency of side effects in our trial was most likely the result of using a relatively high dose of toxin. The dosage used was empirical, based on the dose employed in North America to treat blepharospasm and torticollis, and our own previous experience of treating blepharospasm. However, the toxin employed in the United States is not bioequivalent to that produced in this country and it is now clear that a lower dose should be used to treat torticollis in the United Kingdom. Based on our experience in the trial we now employ a total dose of 25 ng of toxin in males, and 20 ng in females (who have thinner necks), which has eliminated the side effects apart from local pain at the site of injection.
Botulinum toxin appears to be the most effective treatment for torticollis available at present. However, further experience is necessary to define which subgroups of patients are likely to gain the greatest benefit. At present it appears that those with true 923 rotational torticollis and those with pain are easy to treat. Modification of the technique may extend its value to those with more complex head movements.
